Concerning the prophylactic use of G-CSF during cancer chemotherapy:
A) it decreases the duration of neutropenia
B) it decreases the severity of the neutropenic nadir
C) it increases platelet numbers
D) it potentiates the effect of chemotherapy
E) it is only useful in established neutropenia
Correct Answer:
Verified
Q1: Which of the following is more likely
Q2: Patient with metastatic bowel cancer is taking
Q4: Phase 2 trial of new cancer drug.
Q5: Breast cancer, least likely defect:
A)BRCA1
B)BRCA2
C)Bcl-2
D)ATM
E)p53
Q6: In women the biggest risk factor for
Q7: Best treatment of metastatic renal cell cancer:
A)Sutinib
B)Vindarabine
C)Palliative
Q8: Major spread of ovarian cancer
A)Adnexal
B)Lymphatic
C)Blood
D)Peritoneal
E)Seeding
Q9: Patient gets bleomycin, etoposide, and cisplatin. Which
Q10: 55 year female - breast cancer 3
Q11: Cisplatin based chemotherapy. Which anti-emetic is most
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents